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Abstract: Background: The coronavirus disease 2019 (COVID-19) pandemic may have an effect
on maternal anxiety and influence postpartum experience. Objective: To study the prevalence of
maternal anxiety in late pregnancy in the context of the COVID-19 outbreak in Brazil and to analyze
its association with maternal knowledge and concerns about the pandemic. Methods: This was
a national multicenter cross-sectional study performed in 10 different public university hospitals,
between 1 June and 31 August 2020, in Brazil. The inclusion criteria were: maternal age more
than 18 years; gestational age more than 36 weeks at childbirth; single alive newborn without
malformations; and absence of mental disorders. We applied a structured questionnaire to explore
the knowledge and concerns about COVID-19. Maternal anxiety was assessed using the Beck Anxiety
Inventory (BAI). Results: Of the 1662 women interviewed, the BAI score in late pregnancy indicated
that 13.9% presented moderate and 9.6% severe maternal anxiety. Moderate or severe maternal
anxiety was independently associated with the fear of being unaccompanied at childbirth (aOR1.12,
95% CI 1.10–1.35), and independent protective factors were confidence in knowing how to protect
oneself from COVID-19 (aOR0.89, 95% CI 0.82–0.97) and how to safely breastfeed (aOR0.89, 95% CI
0.83–0.95). Conclusion: The COVID-19 pandemic has a significant impact on maternal anxiety.
Keywords: pregnancy; maternal anxiety; childbirth; postpartum; questionnaires; breastfeeding;
coronavirus disease 2019; pandemic
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1. Introduction
The coronavirus disease 2019 (COVID-19) outbreak represents a major source of stress
for pregnant women [1]. This pandemic is a challenge worldwide and interventions to
minimize the impact on people’s quality of life are imperative. Pregnant women have had
to face various factors during the pandemic, including quarantine policies, social isolation,
unemployment, fear of falling ill and having the disease affect loved ones. All of these
factors may negatively impact women’s mental well-being.
On 31 December 2019, the World Health Organization (WHO) received a notification
of cases of atypical pneumonia in the city of Wuhan, China [2]. The first case of this
disease was followed by an epidemic that rapidly took on global proportions. COVID-19,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a
pandemic by WHO on 11 March 2020 [3]. In Brazil, the first case of COVID-19 was detected
on 26 February 2020, in São Paulo (Southeast region). With the increase in the number
of cases and deaths in the country, in April 2020, the health system of Manaus (northern
region) collapsed. In May, some of the cities in the Northeast were placed under lockdown.
On 22 May, due to the rapidly growing number of infections in Brazil, the WHO declared
South America the new epicenter of the pandemic. The highest recorded daily number of
new cases (69,074 cases) and deaths (1595 deaths) occurred on 29 July [4]. High prevalence
of depression (61%) and anxiety (44%) was found in a national online survey applied to
the Brazilian population during the SARS-CoV-2 outbreak [5]. Among pregnant women
evaluated in primary care facilities in Sao Paulo, reported anxiety prevalence was 20.4%
before the COVID-19 pandemic [6].
This outbreak is leading to additional worldwide health problems, such as stress,
anxiety, depressive symptoms, insomnia, denial, anger and fear [7–11]. The COVID-19
pandemic has also increased anxiety among the pregnant population [12]. Corbett et al. [13]
found that pregnant women were the most concerned about their elderly relatives (83%),
followed by concerns related to their children (67%) and their unborn child (63%). Women
were less concerned about their own health; nevertheless, many of them were significantly
anxious. In Wuhan, China, the COVID-19 outbreak increased pregnant women’s anxiety
and affected their decision-making on prenatal care schedules or timing of childbirth, mode
of delivery and infant feeding [14]. Wu et al. [15] reported depressive symptoms in 29.6%
of pregnant women after the epidemic was declared. In Belgium, an online survey during
the lockdown period revealed that 14% of pregnant and breastfeeding women met the
criteria for high anxiety [16]. Interventions targeting maternal stress and isolation, such as
effective communication and psychological support, should be offered to decrease such
mental health effects.
The effects of the pandemic in low- and middle-income settings are underreported.
Mental health in pregnant women during the period of greatest mortality in Brazil due to
COVID-19 has not been assessed. Therefore, the aim of the present study was to evaluate
the prevalence of maternal anxiety in late pregnancy in the context of the COVID-19
outbreak in Brazil and to investigate the association with sociodemographic characteristics
and maternal knowledge and concerns about the pandemic.
2. Material and Methods
This multicenter cross-sectional study was conducted in 10 cities in all five Brazilian re-
gions. This study was approved by each local Research Ethics Committee and by the Brazil-
ian National Ethics Committee—Conep (No. of approval: CAAE-31190120.6.1001.5505).
A written informed consent statement was signed by every woman included in the study.
2.1. Women’s Enrolment
Women who delivered in 10 public university hospitals were recruited from 1 June
2020 to 31 August 2020. Enrolment took place for a period of 60 consecutive days at each
center. All hospitals were linked to a federal or state public university located in 10 cities in
all five geographical regions of Brazil: North (Manaus), Northeast (Natal and Teresina),
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Southeast (São Paulo, Campinas and Botucatu), South (Florianópolis and Porto Alegre)
and Central West (Campo Grande and Brasília) (Figure 1).
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Figure 1. Map of Brazil with the location of the 10 cities in which the study was conducted.
Every university center involved in this study had a local coordinator, who was a
professor at the Department of Obstetrics and Gynecology. Medical residents involved in
data collection were trained to conduct the interviews and to guide women in completing
the forms. Participants were counseled on their concerns about protective measures to
minimize COVID-19 exposure; and cases that required psychological care were referred for
evaluation and follow-up with specialists available at each facility.
Inclusion criteria were the following: maternal age more than 18 years; gestational age
at delivery more than 36 weeks; single alive newborn without malformations; no clinical
suspicion or current diagnosis of COVID-19; absence of diagnosed psychiatric or mental
disorders (such as depression, bipolar disorder, schizophrenia, etc.); and in good health, in
the absence of severe obstetrical/clinical complication during childbirth or intensive care
unit (ICU) admission. Those who agreed to participate were enrolled. Trained medical
residents interviewed postpartum women up to the third day after childbirth before
hospital discharge.
2.2. Questionnaires’ Application
Participants were asked to complete a sociodemographic questionnaire. The questions
addressed maternal age, parity, education, marital status, household income (minimum
salary aver ge guaranteed by law in Brazil is USD194 per month), habits (s oking and
alcohol consumption), pregn ncy complications (hy tensive disorder and diabetes),
companionship during labor, gestational age, mode of del ry, bi th weight, 5-min Apgar
score, history of COVID-19 during pregnancy and history of COVID-19 in the family.
Nex , the participants were ask d to omplete a questionnaire w th state ents ad-
dressing their knowledge and concerns about the pandemic, including information on
prenatal care, and recommendations for childbirth and postpartum (includi g breastfeed-
ing). This questionn ire mp ised fo r domains: general knowledge and preventive care
(4 items), p natal concerns (4 items), cautio s and fe s dur g ch ldbirth (5 it ms), care
and concer s about the newbo n (5 items). Each item receiv d a 5-point Likert sponse
ranging from 1 to 5 (strongly dis gree, p rtially agree, i different, partially agree and fully
agree). This questionnaire was specifically designed for the study, with input provided by
the involved researchers.
The Beck Anxiety Inventory (BAI) was used to measure maternal anxiety. The ques-
tions were answered following brief and standard instructions. The BAI consists of a
21-self-reported-item questionnaire for assessing anxiety level. Each item describes a com-
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mon symptom of anxiety and is rated on a 4-point Likert scale ranging from 0 (not at all)
to 3 (severe). The respondent was asked to rate each symptom and then the total score
was calculated (0–63). A high overall score indicates a high level of anxiety. Anxiety levels
are defined according to the total score as follows: minimal anxiety (0–7), mild anxiety
(8–15), moderate anxiety (16–25), and severe anxiety (26–63) [17]. A validated Brazilian
Portuguese version of the BAI with adequate internal consistency (0.88–0.92) was used in
this study [18,19].
2.3. Statistical Analysis
Data were analyzed using the MedCalc® Statistical Software version 19.5.3 (MedCalc
Software Ltd., Ostend, Belgium; 2020). Descriptive statistics are presented as mean and
standard deviation (SD), median (95% CI), or frequency and percentage (%). The associ-
ations of categorical variables with binary outcomes were analyzed using Fisher’s exact
test or the chi-square test when appropriate. The Mann-Whitney U tests were applied to
continuous variables with non-parametric distribution. The analyses were adjusted for
potential confounders such as maternal age, nulliparity, ethnicity, educational level, marital
status (yes/no), religious belief (yes/no), smoking (yes/no), alcohol consumption (yes/no)
and geographical location. The logistic regression model was used to investigate which
variables were independently associated with increased anxiety. Statistical significance
was set at p < 0.05.
3. Results
During the three-month period, 1683 eligible women were invited to participate in the
study: only 21 refused, with 1662 (98.8%) women completing the questionnaires. Maternal
sociodemographic characteristics, perinatal data and the overall results of the BAI score
are shown in Table 1. Most women were non-white and living with a partner, and the
majority reported educational level up to high school. BAI scores in late pregnancy indicate
that 13.9% presented moderate and 9.6% severe anxiety. There were 3.2% of participants
diagnosed with COVID-19 previously during pregnancy and 5.2% with a family member
diagnosed with COVID-19.
Table 1. Characteristics, perinatal outcomes and maternal anxiety assessed by the Beck Anxiety
Inventory (BAI) at the end of pregnancy during the Coronavirus disease (COVID-19) outbreak in
Brazil (June–August, 2020). (n = 1662).
Characteristics Results
Maternal age, years, mean, SD 28.2 6.5





Asian or Brazilian Indian 22 1.3%
Cohabiting/married 1458 87.7%
Educational level
Below primary school 12 0.7%
Primary school 423 25.5%
Secondary school 982 59.1%
College/university 245 14.7%
Lower class household income—less than USD194/month 1039 62.5%
Religious belief 1330 80.0%
Smoking 70 4.2%








Companionship in labor 1149 69.1%
Gestational age at birth, weeks, mean, SD 39.1 1.3
Birth weight, g, mean, SD 3298 502
Low birth weight (<2500 g) 81 4.9%
Macrosomia (>4000 g) 132 7.9%
5-min Apgar < 7 47 2.8%
COVID-19 during pregnancy 54 3.2%







Mean, SD 9.9 10.4
Median (IQR) 6.0 12.0
Maternal anxiety differed according to geographic region (Table 2). The BAI total score
was significantly higher in women interviewed in the Central West, South and Southeast
than those in the North and in the Northeast. The Northeast exhibited the lowest scores of
all the locations. The Central West region had the highest proportion of moderate or severe
maternal anxiety (39% of respondents) and the Northeast the lowest proportion (8.9%).
The crude and adjusted analyses for confounding factors of the severity of mater-
nal anxiety are shown in Tables 3 and 4. Table 3 shows that the variables “cohabiting
with a partner” (aOR 0.53, 95% CI 0.38–0.75) and “being from the North (aOR 0.49, 95%
CI 0.32–0.77), Northeast (aOR 0.14, 95% CI 0.09–0.21) or Southeast” (aOR 0.57, 95% CI
0.40–0.82) were protective factors for maternal anxiety. The variables “secondary edu-
cational level” (aOR 1.66, 95% CI 1.21–2.29), “alcohol consumption” (aOR 3.5, 95% CI
1.94–6.14) and “having a family member diagnosed with COVID-19” (aOR 1.88, 95% CI
1.11–3.16) were independent factors, significantly associated with moderate or severe ma-
ternal anxiety at the end of pregnancy. Table 4 shows that protective factors for severe
maternal anxiety were “cohabiting with a partner” (aOR 0.51, 95% CI 0.32–0.79) and “being
from the Northeast” (aOR 0.17, 95% CI 0.09–0.31), and that “secondary education” (aOR
2.14, 95% CI 1.30–3.54) or “university educational level” (aOR 2.36, 95% CI 1.26–4.43) were
independently associated with severe maternal anxiety.
Furthermore, women’s knowledge and concerns about the COVID-19 pandemic
were related to moderate or severe maternal anxiety as assessed by the total BAI score
(Table 5). Knowing the signs and symptoms of the disease and having confidence in
self-protection and adequate guidance on breastfeeding were aspects associated with
anxiety. Moderate or severe maternal anxiety was independently associated with the fear
of being unaccompanied at childbirth (aOR 1.12, 95% CI 1.10–1.35). Independent protective
factors were confidence in knowing how to protect oneself from COVID-19 (aOR 0.89, 95%
CI 0.82–0.97) and how to breastfeed during the COVID-19 pandemic (aOR 0.89, 95% CI
0.83–0.95).
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Table 2. Maternal anxiety at end of pregnancy according to geographic regions during the COVID-19 outbreak in Brazil (June–August, 2020).
Geographic Location










Minimal (0–7) 900 (54.2) 110 (36.7) 99 (51.8) 459 (76.8) 105 (39.6) 127 (41.2)
Mild (8–15) 372 (22.4) 73 (24.3) 48 (25.1) 86 (14.4) 69 (26.0) 96 (31.2)
Moderate (16–25) 231 (13.9) 70 (23.3) 26 (13.6) 34 (5.7) 52 (19.6) 49 (15.9)
Severe (26–63) 159 (9.6) 47 (15.7) 18 (9.4) 19 (3.2) 39 (14.7) 36 (11.7)
BAI total score
Mean (SD) 9.9 (10.4) 13.9 (11.4) 10.2 (11.5) 5.3 (7.1) 13.0 (11.0) 11.8 (10.0)
Median (IQR) * 6.0 (12.0) 11 (15.0) a 5 (11.0) b 3 (7.0) c 10 (14.0) d 9 (13.0) e
BAI: Beck Anxiety Inventory. * Kruskal–Wallis test p < 0.001, Post-hoc analysis (Conover): a CW different from N and NE, p < 0.05. b N different from CW, NE, S, SE, p < 0.05. c NE different from CW, N, S, SE,
p < 0.05. d S different from N, NE, p < 0.05. e SE different from N, NE, p < 0.05.
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Table 3. Characteristics of women at birth, complications during pregnancy, and geographic region in Brazil according to moderate or severe maternal anxiety as assessed by the Beck





(n = 390) p Value
a aOR (95% CI) b p Value b
Age, years, median, IR 28 (23, 33) 27 (26, 28) 0.495 - 0.919
Parity 0 484 (38.1) 164 (42.1) 0.157 - 0.685
White ethnicity 310 (24.4) 144 (36.9) <0.001 - 0.054
Black ethnicity 119 (9.4) 47 (12.1) 0.120 - 0.278
Cohabiting/married 1134 (89.2) 324 (83.1) 0.001 0.53 (0.38–0.75) <0.001
Educational level
Secondary school 715 (56.2) 253 (64.9) 0.002 1.66 (1.21–2.29) 0.002
College/university 178 (14.0) 67 (17.2) 0.121 - 0.129
No religious belief 250 (19.7) 82 (21.0) 0.554 - 0.366
Smoking 47 (3.7) 23 (5.9) 0.058 - 0.919
Alcohol consumption 42 (3.3) 27 (6.9) 0.002 3.5 (1.94–6.14) <0.001
COVID-19 during pregnancy 38 (3.0) 16 (4.1) 0.277 - 0.625
COVID-19 in the family 55 (4.3) 31 (7.9) 0.005 1.88 (1.11–3.16) 0.019
Maternal complications
Hypertensive disorders 435 (34.2) 92 (23.6) <0.001 - 0.385
Diabetes mellitus c 213 (16.7) 57 (14.6) 0.319 - 0.235
Geographic location
Central West 183 (14.4) 117 (30.0) - - -
North 147 (11.6) 44 (11.3) <0.001 0.49 (0.32–0.77) 0.002
Northeast 545 (42.8) 53 (13.6) <0.001 0.14 (0.09–0.21) <0.001
South 174 (13.7) 91 (23.3) 0.252 - 0.144
Southeast 223 (17.5) 85 (21.8) 0.003 0.57 (0.40–0.82) 0.002
Data are presented as median (interquartile range) or number (percentage). a Chi-square test. b Logistic regression to identify independent variables. c Pregestational and gestational diabetes mellitus.
Variables considered for adjusted OR: age, parity, maternal race, cohabitating, educational level, religious belief, smoking, alcohol consumption, COVID-19 during pregnancy, COVID-19 in the family, maternal
complications and geographic location. aOR: adjusted odds ratio; CI: confidence interval.
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Table 4. Characteristics of women, complications during pregnancy, and Brazilian geographic regions according to severe maternal anxiety as assessed by the Beck Anxiety Inventory





(n = 159) p Value
a aOR (95% CI) b p Value b
Age, years, median, IR 27 (23, 33) 27 (22, 32) 0.209 - 0.2588
Parity 0 579 (38.5) 69 (43.4) 0.231 - 0.9643
White ethnicity 392 (26.1) 62 (39.0) <0.001 - 0.2193
Black ethnicity 146 (9.7) 20 (12.6) 0.252 - 0.3257
Cohabiting/married 1330 (88.5) 128 (80.5) 0.004 0.51 (0.32–0.79) 0.0030
Educational level
Secondary school 863 (57.4) 105 (66.0) <0.001 2.14 (1.30–3.54) 0.0030
College/university 213 (14.2) 32 (20.1) <0.001 2.36 (1.26–4.43) 0.0074
No religious belief 299 (19.9) 33 (20.8) 0.796 - 0.5077
Smoking 59 (3.9) 11 (6.9) 0.074 - 0.3505
Alcohol consumption 61 (4.1) 8 (5.0) 0.559 - 0.3008
COVID-19 during pregnancy 46 (3.1) 8 (5.0) 0.183 - 0.9624
COVID-19 in the family 71 (4.7) 15 (9.4) 0.011 - 0.0745
Maternal complications
Hypertensive disorders 485 (32.3) 42 (26.4) 0.132 - 0.0718
Diabetes mellitus c 245 (16.3) 25 (15.7) 0.851 - 0.8603
Geographic location
Central West 253 (16.8) 47 (29.6) - - -
North 173 (11.5) 18 (11.3) 0.047 - 0.2317
Northeast 579 (38.5) 19 (11.9) <0.001 0.17 (0.09–0.31) <0.0001
South 226 (15.0) 39 (24.5) 0.754 - 0.6892
Southeast 272 (18.1) 36 (22.6) 0.154 - 0.1748
Data are presented as median (interquartile range) or number (percentage). a Chi-square test. b Logistic regression to identify independent variables. c Pregestational and gestational diabetes mellitus. Variables
considered to be adjusted the OR: age, parity, maternal race, cohabitating, educational level, religious belief, smoking, alcohol consumption, COVID-19 during pregnancy, COVID-19 in the family, maternal
complications and geographic location. aOR: adjusted odds ratio; CI: confidence interval.
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Median Average Rank Median Average Rank p Value a aOR (95% CI) b p Value b
Knowledge and preventive care - -
I am afraid of getting COVID-19. 5 834.5 5 821.8 0.581 - -
I know the signs and symptoms of COVID-19. 5 851.5 4 766.3 0.001 - -
I received information about care in the pandemic. 5 826.9 5 846.3 0.350 - -
I feel confident in protecting myself from COVID-19. 5 855.0 4 755.0 0.000 0.89 (0.82–0.97) 0.007
Prenatal concerns
I was worried about COVID-19 affecting my baby during pregnancy. 5 824.5 5 854.2 0.118 - -
I was instructed on caring for the newborn. 5 836.8 5 814.3 0.369 - -
I was guided on breastfeeding during COVID-19. 5 828.4 4.5 841.7 0.600 - -
I was worried about prenatal difficulties. 5 828.0 5 842.9 0.514 - -
Cautions and fears during childbirth
I received guidance on childbirth care due to COVID-19. 4 849.8 4 772.0 0.003 - -
My companion was afraid of COVID-19 at delivery. 5 837.2 5 813.0 0.337 - -
I was worried about giving birth at the hospital. 5 823.5 5 857.5 0.183 - -
I was afraid to be without a companion in childbirth. 5 809.6 5 902.9 <0.0001 1.12 (1.10–1.35) <0.001
I was worried that childbirth care might be compromised due to COVID-19. 5 824.1 5 855.5 0.218 - -
Care and concerns about the newborn
I learned how to breastfeed due to COVID-19. 5 858.0 4 745.1 <0.0001 0.89 (0.83–0.95) 0.001
I feel confident to breastfeed despite COVID-19. 5 854.6 5 756.3 <0.0001 - -
I’m worried about having COVID-19. 5 836.3 5 815.8 0.382 - -
I’m worried that my baby has COVID-19. 5 841.4 5 799.3 0.089 - -
I’m worried about my baby having COVID-19 after birth. 5 825.7 5 850.5 0.261 - -
a Mann–Whitney test. b Logistic regression with stepwise procedure to select independent variables. aOR: adjusted odds ratio; CI: confidence interval.
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4. Discussion
To the best of our knowledge, this is the first study in Brazil to investigate maternal
anxiety in late pregnancy during the COVID-19 outbreak and to examine its association
with knowledge and concerns regarding childbirth. Our study found moderate or severe
anxiety in 23.4% of the women at the end of pregnancy. Moderate or severe maternal
anxiety was related to social factors such as educational level, living with a partner, alcohol
consumption and having a family member diagnosed with COVID-19. Concerns that
increased maternal anxiety were mainly related to confidence in self-protection from
COVID-19, doubts regarding the presence of a companion during childbirth and safety
of breastfeeding.
Preventive actions and treatment of COVID-19 in the obstetric scenario are daunting
tasks requiring the optimization of both the mother and the baby’s health care. The
potential effects of maternal infection on the fetus and the newborn are a source of concern
and insecurity [20]. COVID-19 during pregnancy is associated with an increased risk of
adverse maternal and perinatal outcomes and severe disease [21]. In addition, in Brazil,
Takemoto et al. [22] reported increased maternal deaths and delays associated with health
care: a large proportion of deaths occurred without intensive care or ventilatory support.
They found a case fatality rate of 12.7% among women with severe acute respiratory
syndrome due to COVID-19 during pregnancy and the postpartum period.
Anxiety status and the factors influencing it may differ according to the severity of
the outbreak in each geographic region. In the present study, data were collected from
all geographic regions in Brazil during the same time period. Maternal anxiety was more
prevalent and more severe in the Central West and in the South. In the months the inter-
views were conducted, the number of COVID-19 cases was still low in the North and in the
Northeast and was increasing in the South and in the Central West. This may have influ-
enced the prevalence of mental health disorders in the women. The notifications of deaths
could potentially impact maternal mental health, and the risk of anxiety disorders may
have increased as a result. The same was reported by Liu et al. [14], who found differences
between cities: more women in Wuhan (epicenter) felt anxious than in Chongqing, a less
affected city (24.5% vs. 10.4%). Brazil is a country of continental size, with great disparities
among regions, not only in the number of COVID-19 cases, but also in social, cultural and
economic characteristics.
Anxiety due to COVID-19, as assessed by a specific instrument, significantly influ-
enced social attitudes [23]. The prevalence of psychological problems associated with social
isolation during the COVID-19 epidemic in China was verified through an online survey,
which specifically detected high rates of anxiety, depression, alcohol consumption and
poor mental well-being among Chinese people [24]. Pregnant women assessed after the
declaration of the COVID-19 epidemic in China had mean depressive scores and anxiety
subscale scores which were significantly higher than those before the declaration. The
higher risk for depressive symptoms included people with an annual middle household
income and low levels of physical exercise [15]. In the present study, the role of family
income was not analyzed but, contrary to the finding of Wu et al. [15], higher educational
levels increased significantly the risk of severe maternal anxiety.
The uncertainty about the best treatment and clinical management of patients with
COVID-19 may affect the mind and psyche of pregnant women, with implications for their
health care experiences [25]. Depression and anxiety are associated, and both can occur
due to the COVID-19 pandemic [26]. Uncertain prognosis, social isolation, restriction of
individual freedoms, financial losses, decline in quality of life and conflicting messages from
government authorities may add up as stressors and possibly trigger mental health crises.
At the hospital, childbirth care must prioritize maternal safety. The removal of per-
sonal items, the reduction in the number of visitors and companions, the reduction in the
team assisting childbirth, the use of masks and personal protective equipment by all profes-
sionals are measures that possibly impact the expectations [27] of these pregnant women
about the experience of childbirth. In Italy, Ravaldi et al. [28] reported birth expectations
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completely changed after the onset of COVID-19 to include fear, sadness and uncertainty.
Ahlers–Schmidt et al. [29] carried out an electronic survey with a 51% response rate of preg-
nant women or mothers of infants less than 12 months, 82.5% of whom reported changes in
mental status, including an increase of anxious thoughts related to the COVID-19 pandemic
of 50%. In Italy, almost half of the women (46%) in an interview reported high anxiety
regarding risks of vertical transmission of the disease [30]. In the present study, we found
that maternal anxiety was associated with concerns related to the moment of delivery and
breastfeeding as a consequence of the pandemic.
An online survey investigated maternal mental health status after a few weeks of
lockdown in Belgium using the Generalized Anxiety Disorder 7-item Scale [16]. It revealed
higher levels of overall anxiety among pregnant women, 8.4% of whom had moderate
anxiety and 5.2% of whom had severe anxiety. The social isolation measures brought
on by COVID-19 may be a great burden on the emotional well-being of women in the
initial postpartum period. We found 13.9% cases of moderate anxiety and 9.6% cases of
severe anxiety. We also found that insecurity with respect to breastfeeding and fear of
being unaccompanied at childbirth were associated with higher scores on the total BAI,
indicating that counseling for such issues should be improved during antenatal care and at
hospital admission.
Nodoushan et al. [31] evaluated the spiritual and mental health of pregnant women
and COVID-19 anxiety during the pandemic in Iran, and found direct and significant
association. In Pakistan, 36% of pregnant women interviewed stated the perception that
the COVID-19 pandemic had a large impact on their mental health [32].
It is important for women to have adequate support, which includes health care
workers and companions during labor and childbirth. It is up to midwives and obstetricians
to help women regain self confidence and trust in caregivers. Educational programs should
be designed to address pregnant women’s perceptions of the COVID-19 pandemic in order
to improve their mental well-being.
In this study, the models were constructed with maternal anxiety categorized as
minimal or mild versus moderate or severe and also not severe versus severe because this
level of anxiety was considered relevant for the Brazilian population and the proposed
model was intended to enable the evaluation of factors associated with increased anxiety.
The relationship between severe anxiety and women’s educational level possibly indicates
the influence of social inequalities on access to information and perception of severity.
Strengths and Limitations
The strength of this study lies in the inclusion of 10 cities in all geographic regions
in Brazil, most of which are state capitals, during the time when South America was the
epicenter of COVID-19 pandemic in the world. Additionally, the women were interviewed
face-to-face, not through online electronic forms or phone calls, and by trained doctors who
were available to answer questions and minimize concerns. Our study has the limitation of
including only participants from the public sector in university hospitals, which admit high-
and low-risk pregnant women for childbirth. Patients who were suspected or confirmed
cases of COVID-19 at admission for childbirth were not included. Had they been included,
the results might have been different. In addition, when previous COVID-19 infection was
reported during the interview, no detailed information was collected regarding the symp-
toms or diagnostic testing at the time of infection. Additionally, unfortunately, variables of
postpartum depression or measure of optimism for any scale were not collected. Another
limitation is that the emergence of COVID-19 was different in the diverse geographic
regions. The disease started in the Southeast, the North and the Northeast. Furthermore,
there were organizational differences in the health systems among cities, which may have
influenced quality of health care during the period.
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5. Conclusions
Many questions remain unanswered regarding the ongoing pandemic and a scenario
of uncertainty continues. Highlighting mental health problems, especially anxiety among
the general population and among pregnant women, is of paramount importance during
public health emergencies. Our findings show that the impact of COVID-19 has been
significant on maternal anxiety, especially with concerns about limitations for a companion
during childbirth and breastfeeding safety. Lack of a partner, high educational level,
consumption of alcohol and a family member with COVID-19 increased the risk for higher
levels of anxiety. As Brazil is currently registering a new increase in COVID-19 cases, we
urge authorities to prioritize women’s health and consider immediate interventions in
order to provide recommendations to reduce the impacts of the pandemic on mental health.
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